CCM Investment Group’s Pfizer PFE Stock Holding History

CCM Investment Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$5.77M	Buy	228,990 +10,990	+5%	+$288K	0.61%	25
2024 Q4	$5.76M	Buy	+218,000	New	+$5.91M	0.63%	21

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM Investment Group's PFE Position: Q1 2025 in Review

CCM Investment Group increased its Pfizer (PFE) stake by 5% in Q1 2025, buying an estimated $288K and bringing the position to 228,990 shares worth $5.77M. The position accounts for 0.61% of the portfolio, ranked #25.

CCM Investment Group first reported a position in PFE in Q4 2024 and has held it in 2 quarters since. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

CCM Investment Group held 228,990 shares of Pfizer worth $5.77M as of Q1 2025.
CCM Investment Group bought 10,990 Pfizer shares in Q1 2025, an estimated $288K.
Pfizer made up 0.61% of CCM Investment Group's portfolio in Q1 2025, its #25 holding.
CCM Investment Group first reported a position in Pfizer in Q4 2024 and has held it in 2 quarters since.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on CCM Investment Group's 13F filing for Q1 2025, filed 12 May 2025.